Improving Care and Empowering Adults Living with SMA: A Call to Action in the New Treatment Era.

Adults living with SMA Burden of Disease (BoD) Neuromuscular Disease (NMD) Quality of Life (QoL) Spinal Muscular Atrophy (SMA) health services lived experience transition

Journal

Journal of neuromuscular diseases
ISSN: 2214-3602
Titre abrégé: J Neuromuscul Dis
Pays: Netherlands
ID NLM: 101649948

Informations de publication

Date de publication:
2021
Historique:
pubmed: 2 3 2021
medline: 21 12 2021
entrez: 1 3 2021
Statut: ppublish

Résumé

While Spinal Muscular Atrophy (SMA) has historically been managed with supportive measures, the emergence of innovative medicines has given those living with SMA hope for improved quality of life and has revolutionized care. Despite these advances, the use of therapies and changes in disease management strategies have focused on pediatric populations, leaving adults living with SMA, and those transitioning into adulthood, relatively neglected. Through a multi-faceted approach that gathered unbiased perspectives from clinical experts, validated insights from individuals with lived experiences, and substantiated findings with evidence from the literature, we have exposed unmet needs that are hindering the field and, ultimately, impacting care and quality of life for adults living with SMA. Here, we set new aspirations and calls to action to inspire continued research in this field, stimulate dialogue across the SMA community and inform policies that deliver effective management and care throughout an adult's journey living with SMA.

Identifiants

pubmed: 33646175
pii: JND200611
doi: 10.3233/JND-200611
pmc: PMC8385518
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

543-551

Références

J Pediatr Orthop. 2011 Jun;31(4):450-4
pubmed: 21572284
J Neuromuscul Dis. 2019;6(4):453-465
pubmed: 31594243
Neurology. 2018 Sep 25;91(13):e1206-e1214
pubmed: 30143566
J Child Neurol. 2013 Nov;28(11):1517-1520
pubmed: 23034979
Lancet Neurol. 2020 Apr;19(4):317-325
pubmed: 32199097
Ann Neurol. 2011 Mar;69(3):437-44
pubmed: 21391239
Orphanet J Rare Dis. 2016 May 04;11(1):58
pubmed: 27145956
Lancet Neurol. 2020 Jul;19(7):564-565
pubmed: 32562673
Eur J Neurol. 2021 Feb;28(2):602-608
pubmed: 33012052
Phys Med Rehabil Clin N Am. 2012 Aug;23(3):689-99
pubmed: 22938882
Muscle Nerve. 2016 Nov;54(5):850-855
pubmed: 27074445
J Med Econ. 2020 Jan;23(1):70-79
pubmed: 31322019
Orphanet J Rare Dis. 2021 Feb 22;16(1):96
pubmed: 33618755
Muscle Nerve. 2018 Dec;58(6):805-811
pubmed: 30028531
BMC Neurol. 2017 Apr 4;17(1):68
pubmed: 28376816
J Adv Nurs. 2016 Nov;72(11):2695-2705
pubmed: 27293032
Neuromuscul Disord. 2017 May;27(5):428-438
pubmed: 28237437
Neuromuscul Disord. 2018 Feb;28(2):103-115
pubmed: 29290580
Muscle Nerve. 2020 Jul;62(1):46-49
pubmed: 32329921
Orphanet J Rare Dis. 2019 Apr 2;14(1):74
pubmed: 30940178
Clin Ther. 2019 May;41(5):943-960.e4
pubmed: 31056304
J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1166-1174
pubmed: 32917822
Disabil Rehabil. 2020 Aug 17;:1-9
pubmed: 32805149
Patient. 2020 Aug;13(4):389-400
pubmed: 32266662
N Engl J Med. 2017 Nov 2;377(18):1723-1732
pubmed: 29091570
Disabil Rehabil. 2020 Aug;42(16):2262-2270
pubmed: 30696284
BMC Neurol. 2015 Oct 24;15:217
pubmed: 26499462
Orphanet J Rare Dis. 2019 Jan 21;14(1):18
pubmed: 30665421
Neuromuscul Disord. 2019 Apr;29(4):321-329
pubmed: 30954388
Muscle Nerve. 2020 Feb;61(2):222-226
pubmed: 31773738
Neuromuscul Disord. 2018 Mar;28(3):197-207
pubmed: 29305137
BMJ Open. 2019 Nov 21;9(11):e031271
pubmed: 31753879
Respir Med. 2018 Mar;136:98-110
pubmed: 29501255
Dev Neurorehabil. 2010 Feb;13(1):10-8
pubmed: 20067341
Lancet Neurol. 2020 Apr;19(4):283-284
pubmed: 32199087

Auteurs

Maggie C Walter (MC)

Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians-University of Munich, Munich, Germany.

Claudia Chiriboga (C)

Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.

Tina Duong (T)

Stanford University, Stanford, CA, United States.

Nathalie Goemans (N)

Faculty of Medicine, University of Leuven, University Hospitals Leuven, Leuven, Belgium.

Anna Mayhew (A)

Newcastle University Translational and Clinical Research Institute, Newcastle upon Tyne, UK.

Laëtitia Ouillade (L)

AFM Téléthon, European Patients' Forum Young Patient.

Maryam Oskoui (M)

Departments of Pediatrics and Neurology, McGill University, Montreal, QC, Canada.

Ros Quinlivan (R)

MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.

Juan F Vázquez-Costa (JF)

Motor Neuron Disease Unit, Department of Neurology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

John Vissing (J)

Copenhagen Neuromuscular Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Laurent Servais (L)

MDUK Neuromuscular Center, Department of Paediatrics, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH